...
首页> 外文期刊>Expert Review of Molecular Diagnostics >Update on bipolar disorder biomarker candidates
【24h】

Update on bipolar disorder biomarker candidates

机译:有关双相情感障碍生物标志物候选物的最新信息

获取原文
获取原文并翻译 | 示例

摘要

Introduction: Bipolar disorder is a chronic and disabling mood disorder with a complex pathophysiological basis. A significant percentage of patients do not receive correct diagnosis which directly influences therapeutic response, rendering recovery troublesome. There is a long-standing need for proper non-clinically based tools for diagnosis, treatment selection and follow-up of such patients.Areas covered: In the past decade, the scientific community has shown a great interest in biomarker development. Here, we highlight the different potential biomarkers and we discuss their feasibility and their possible clinical relevance.Expert commentary: To date, despite the major ongoing trials and consortia with promising future perspectives, no reliable biomarker of bipolar disorder has been fully defined.
机译:简介:双相情感障碍是一种慢性致残性情绪障碍,具有复杂的病理生理基础。很大比例的患者没有接受直接影响治疗反应的正确诊断,从而使恢复变得困难。长期以来,一直需要适当的基于非临床的工具来诊断,选择和随访此类患者。涉及领域:在过去的十年中,科学界对生物标志物的开发表现出极大的兴趣。在这里,我们重点介绍了不同的潜在生物标志物,并讨论了它们的可行性及其可能的临床意义。专家评论:迄今为止,尽管正在进行大规模的试验和财团,并且前景广阔,但尚未完全确定双相情感障碍的可靠生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号